An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)
Abstract
Authors
C. Rinciog K.J. Myrén M. Aldén A. Diamantopoulos C. LeReun
C. Rinciog K.J. Myrén M. Aldén A. Diamantopoulos C. LeReun
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now